Historical
I/LA02-A
Quality Assurance for the Indirect Immunofluorescence Test for Autoantibodies to Nuclear Antigen (IF-ANA); Approved Guideline
Provides guidance for laboratorians who perform immunofluorescence tests for autoantibodies to nuclear antigen to detect diseases. Topics addressed include substrate and fixative variations, fluorescence-labeled conjugates, reference intervals, test results, and criteria for classification of systemic lupus erythematosus. FDA
CONTENT PROVIDER
Clinical And Laboratory Standards Institute [clsi]
Clinical And Laboratory Standards Institute [clsi]